P. Maroto Rey

Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study

M. Bickel, J. Rockstroh, I. Krznaric, 2021, Cancer.

Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinoma.

F. Algaba, Ó. Rodríguez Faba, A. Rosales, 2010, European urology.

Sorafenib: Tolerance in Patients on Chronic Hemodialysis

H. Villavicencio, P. Maroto Rey, 2008, Oncology.

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Fernando Maciel Barbosa, Raymond J. McDermott, J. Burke, 2022, The Lancet. Oncology.

[Molecular biology of the clear cell renal cell carcinoma: principles for a selective treatment].

E. Grande Pulido, P. Maroto Rey, E. Solsona Narbón, 2007, Actas Urológicas Españolas.